ResearcherApex Therapeutics, Inc.No recent work listed

Martin F Haslanger

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on NIH RePORTER profile ID 9572480. Sources: NIH RePORTER.

Their work

Papers: 0
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2013: 1 grant

Grants 1

Novel Therapeutic Strategy for Refractory and Relapse Childhood Acute Leukemia R43CA171344 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mark R. Kelley · 1 shared grant, 2013 · strength 0.15
- Grant Novel Therapeutic Strategy for Refractory and Relapse Childhood Acute Leukemia R43CA171344 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.